97 related articles for article (PubMed ID: 23207411)
21. Design and synthesis of novel inhibitors of human kynurenine aminotransferase-I.
Akladios FN; Nadvi NA; Park J; Hanrahan JR; Kapoor V; Gorrell MD; Church WB
Bioorg Med Chem Lett; 2012 Feb; 22(4):1579-81. PubMed ID: 22281190
[TBL] [Abstract][Full Text] [Related]
22. Impact on farnesyltransferase inhibition of 4-chlorophenyl moiety replacement in the Zarnestra series.
Angibaud P; Mevellec L; Meyer C; Bourdrez X; Lezouret P; Pilatte I; Poncelet V; Roux B; Merillon S; End DW; Van Dun J; Wouters W; Venet M
Eur J Med Chem; 2007 May; 42(5):702-14. PubMed ID: 17316920
[TBL] [Abstract][Full Text] [Related]
23. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of o-trifluoromethylbiphenyl substituted 2-amino-nicotinonitriles as inhibitors of farnesyltransferase.
Wang GT; Wang X; Wang W; Hasvold LA; Sullivan G; Hutchins CW; O'Conner S; Gentiles R; Sowin T; Cohen J; Gu WZ; Zhang H; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2005 Jan; 15(1):153-8. PubMed ID: 15582430
[TBL] [Abstract][Full Text] [Related]
25. New halogenated phenylcoumarins as tyrosinase inhibitors.
Matos MJ; Santana L; Uriarte E; Delogu G; Corda M; Fadda MB; Era B; Fais A
Bioorg Med Chem Lett; 2011 Jun; 21(11):3342-5. PubMed ID: 21514152
[TBL] [Abstract][Full Text] [Related]
26. Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity.
Kettler K; Wiesner J; Silber K; Haebel P; Ortmann R; Sattler I; Dahse HM; Jomaa H; Klebe G; Schlitzer M
Eur J Med Chem; 2005 Jan; 40(1):93-101. PubMed ID: 15642414
[TBL] [Abstract][Full Text] [Related]
27. Novel triazole based inhibitors of Ras farnesyl transferase.
Saha AK; Liu L; Simoneaux R; DeCorte B; Meyer C; Skrzat S; Breslin HJ; Kukla MJ; End DW
Bioorg Med Chem Lett; 2005 Dec; 15(24):5407-11. PubMed ID: 16216509
[TBL] [Abstract][Full Text] [Related]
28. Discovery of novel xanthone derivatives as xanthine oxidase inhibitors.
Hu L; Hu H; Wu W; Chai X; Luo J; Wu Q
Bioorg Med Chem Lett; 2011 Jul; 21(13):4013-5. PubMed ID: 21620698
[TBL] [Abstract][Full Text] [Related]
29. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.
Puntambekar D; Giridhar R; Yadav MR
Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of novel 2-arylamino-3-(arylsulfonyl)quinoxalines as PI3Kα inhibitors.
Wu P; Su Y; Liu X; Zhang L; Ye Y; Xu J; Weng S; Li Y; Liu T; Huang S; Yang B; He Q; Hu Y
Eur J Med Chem; 2011 Nov; 46(11):5540-8. PubMed ID: 21945250
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of potent hydroxyethylamine (HEA) BACE-1 inhibitors carrying prime side 4,5,6,7-tetrahydrobenzazole and 4,5,6,7-tetrahydropyridinoazole templates.
Sund C; Belda O; Borkakoti N; Lindberg J; Derbyshire D; Vrang L; Hamelink E; Åhgren C; Woestenenk E; Wikström K; Eneroth A; Lindström E; Kalayanov G
Bioorg Med Chem Lett; 2012 Nov; 22(21):6721-7. PubMed ID: 23010268
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
[TBL] [Abstract][Full Text] [Related]
33. On the discovery of new potent human farnesyltransferase inhibitors: emerging pyroglutamic derivatives.
Homerin G; Lipka E; Rigo B; Farce A; Dubois J; Ghinet A
Org Biomol Chem; 2017 Oct; 15(38):8110-8118. PubMed ID: 28905970
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, biochemical, and cellular evaluation of farnesyl monophosphate prodrugs as farnesyltransferase inhibitors.
Clark MK; Scott SA; Wojtkowiak J; Chirco R; Mathieu P; Reiners JJ; Mattingly RR; Borch RF; Gibbs RA
J Med Chem; 2007 Jul; 50(14):3274-82. PubMed ID: 17555307
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1).
Ma L; Yang Z; Li C; Zhu Z; Shen X; Hu L
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):643-8. PubMed ID: 21222511
[TBL] [Abstract][Full Text] [Related]
36. Exploring isoxazoles and pyrrolidinones decorated with the 4,6-dimethoxy-1,3,5-triazine unit as human farnesyltransferase inhibitors.
Lucescu L; Ghinet A; Shova S; Magnez R; Thuru X; Farce A; Rigo B; Belei D; Dubois J; Bîcu E
Arch Pharm (Weinheim); 2019 May; 352(5):e1800227. PubMed ID: 30947375
[TBL] [Abstract][Full Text] [Related]
37. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides.
Mitsch A; Wissner P; Silber K; Haebel P; Sattler I; Klebe G; Schlitzer M
Bioorg Med Chem; 2004 Sep; 12(17):4585-600. PubMed ID: 15358286
[TBL] [Abstract][Full Text] [Related]
38. QSAR study on tetrahydroquinoline analogues as plasmodium protein farnesyltransferase inhibitors: a comparison of rationales of malarial and mammalian enzyme inhibitory activities for selectivity.
Gupta MK; Prabhakar YS
Eur J Med Chem; 2008 Dec; 43(12):2751-67. PubMed ID: 18329140
[TBL] [Abstract][Full Text] [Related]
39. Ultrasounds-mediated 10-seconds synthesis of chalcones as potential farnesyltransferase inhibitors.
Homerin G; Nica AS; Farce A; Dubois J; Ghinet A
Bioorg Med Chem Lett; 2020 Jun; 30(11):127149. PubMed ID: 32247731
[TBL] [Abstract][Full Text] [Related]
40. Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites.
Glenn MP; Chang SY; Hucke O; Verlinde CL; Rivas K; Hornéy C; Yokoyama K; Buckner FS; Pendyala PR; Chakrabarti D; Gelb M; Van Voorhis WC; Sebti SM; Hamilton AD
Angew Chem Int Ed Engl; 2005 Aug; 44(31):4903-6. PubMed ID: 16007716
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
